|
 |
European Pharmaceutical Contractor
|
Across every industry, managers and workers are finding themselves continually wading through what is rapidly becoming a mountain of information. The Internet, regulation and computerisation have all played a part.
The laboratory has felt the growth in data particularly acutely. As the pharmaceutical and biotechnology industries strive to bring a greater number of drugs to market more quickly, labs are under pressure to screen a much wider range of prospective drug candidates. Whilst information systems (IS) make it easier to manage the volume of data spawned as a result of regulatory and competitive pressures, it also makes copious amounts of data available in volumes that many labs find difficult to manage.
The Origins of the Data Mountain: Competition and the Need for Speed
Companies are endeavouring to reduce time to market for new products and develop a greater number of new drugs per year. Typically, the business needs innovative new products to win market share, and it needs them more quickly than the competition. Consequently, the lab finds itself under pressure to develop procedures that facilitate screening an increasing number of prospective drug candidates at the beginning of a new product development cycle.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
“PACK DIFFERENT” with EMBALLAGE 2008
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
